Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox PR...
Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study PR...
Fostrox + Lenvima demonstrates further improvement in durable clinical benefit in HCC, supporting the accelerated development plan PR...
Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated...
Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway PR Newswire STOCKHOLM, Dec. 6, 2023...
Medivir to present at the Carlsquare Equity Research Investor Day PR Newswire STOCKHOLM, Dec. 6, 2023 STOCKHOLM, Dec. 6, 2023 /PRNewswire/...
Bulletin from Extraordinary General Meeting in Medivir AB (publ) PR Newswire STOCKHOLM, Dec. 1, 2023 STOCKHOLM, Dec. 1, 2023 /PRNewswire/...
Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC PR...
Medivir to present at the Redeye Life Science Day PR Newswire STOCKHOLM, Nov. 22, 2023 STOCKHOLM, Nov. 22, 2023 /PRNewswire/ -- Medivir AB...
Medivir to present at the Erik Penser Bank Company Event PR Newswire STOCKHOLM, Nov. 21, 2023 STOCKHOLM, Nov. 21, 2023 /PRNewswire/ -- Medivir AB...
Medivir to present clinical data at ASCO-GI with fostrox + Lenvima in HCC and shares positive response from Type D meeting with FDA PR...
Notice of Extraordinary General Meeting in Medivir AB (publ) PR Newswire STOCKHOLM, Nov. 7, 2023 STOCKHOLM, Nov. 7, 2023 /PRNewswire/ -- The...
MEDIVIR AB - INTERIM REPORT JANUARY - SEPTEMBER 2023 PR Newswire STOCKHOLM, Oct. 27, 2023 STOCKHOLM, Oct. 27, 2023 /PRNewswire/ -- Updated data...
Medivir to report new and updated data from ongoing phase 2a HCC study as part of its Q3 report on Friday PR Newswire STOCKHOLM, Oct. 25, 2023...
Nomination Committee of Medivir appointed PR Newswire STOCKHOLM, Oct. 23, 2023 STOCKHOLM, Oct. 23, 2023 /PRNewswire/ -- Medivir AB (Nasdaq...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지